Connecticut 2025 Regular Session

Connecticut Senate Bill SB00792

Introduced
1/21/25  

Caption

An Act Imposing An Excise Tax On The Sale Of Non-tobacco Nicotine Products.

Summary

SB 792 would amend the general statutes to impose a 75% excise tax on the sale of non-tobacco nicotine products. The bill is aimed at products that contain nicotine but are not tobacco-based, which would likely include items such as nicotine pouches and other alternative nicotine products sold in the state. By creating a new excise tax category, the bill would expand the state’s taxing authority over nicotine products beyond traditional tobacco goods. The tax would apply at the point of sale and would likely affect retailers, distributors, and consumers of non-tobacco nicotine products, potentially increasing retail prices and changing market demand for these products.

Impact

The bill would change state tax law by adding a 75% excise tax on non-tobacco nicotine products, creating a new revenue source and a new compliance obligation for sellers of these products. It would affect businesses that sell nicotine pouches and similar products, and could also influence consumer purchasing behavior by making these products significantly more expensive relative to untaxed or differently taxed alternatives.

Sentiment

There is no recorded committee transcript or vote history available for this bill, so no formal legislative sentiment can be determined from the provided materials. Based on the bill’s purpose, it appears to reflect a regulatory and revenue-focused approach to nicotine products rather than a broad policy consensus or controversy documented in the record provided.

Contention

The main likely point of contention is the size of the tax—75% is substantial and may be viewed by supporters as a public health measure to discourage nicotine use, while opponents may argue it is overly burdensome on consumers and businesses. Another possible issue is whether non-tobacco nicotine products should be treated similarly to tobacco for tax purposes, especially if these products are marketed as harm-reduction or smoking-cessation alternatives.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.